The Cure JM Foundation produces a monthly newsletter with the latest news and updates about juvenile myositis. Please click below to read past issues of the Family News.

Anifrolumab: A New Monoclonal Antibody Therapy for Juvenile Dermatomyositis and What Families Should Know
Based on presentations and an expert panel at Cure JM’s January 2026 Virtual Summit on JIIM Research & Care At the January 2026 Cure JM

